GENE ONLINE|News &
America’s Ongoing Battle For Lower Insulin Prices
The cost of healthcare in America is astronomical, and insulin prices are a heavy burden on millions of Americans each month. In March, the U.S. House of Representatives passed the Affordable Insulin Now Act to cap insulin prices for insured individuals to $35 a month. The bill appears optimistic for people with diabetes, but the text raises questions about who will actually benefit from lower insulin prices and who may have to pay the same as they have been.
Why Insulin Is A Focal Point For Legislation
Insulin is used to treat diabetes by helping blood sugar enter the body’s cells to create energy. It also signals the liver to store blood sugar for later use, which helps regulate normal organ function. Without insulin, patients with diabetes can develop problems like heart disease, vision loss, and kidney disease.
GO Prime with only $1.49 now
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
